<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="MELA-AU_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002157">
		<TITLE>ICGC PCAWG Dataset: MELA-AU_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: MELA-AU.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001230402"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230391"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230383"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230419"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230376"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230453"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230416"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230423"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230442"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230446"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230451"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230468"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230389"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230373"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230436"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230369"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230465"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230374"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230372"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230366"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230403"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230457"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230440"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230346"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230431"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230441"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230418"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230450"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230398"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230352"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230481"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230456"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230458"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230355"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230387"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230377"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230354"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230480"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230472"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230477"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230412"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230434"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230425"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230350"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230378"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230420"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230463"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230356"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230363"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230459"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230478"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230392"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230370"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230445"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230467"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230474"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230375"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230466"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230439"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230348"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230390"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230359"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230424"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230426"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230385"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230429"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230415"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230368"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230367"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230357"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230449"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230409"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230452"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230351"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230410"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230460"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230455"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230395"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230430"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230427"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230405"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230470"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230361"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230448"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230362"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230421"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230393"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230422"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230479"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230438"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230379"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230407"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230454"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230408"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230464"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230365"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230360"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230349"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230400"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230444"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230401"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230447"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230432"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230345"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230397"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230371"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230461"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230462"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230443"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230413"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230344"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230435"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230358"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230404"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230428"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230380"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230386"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230471"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230414"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230469"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230353"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230396"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230394"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230476"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230417"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230381"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230437"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230382"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230347"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230482"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230483"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230399"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230388"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230473"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230475"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230411"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230406"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230384"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230433"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230364"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>